<DOC>
	<DOCNO>NCT01970774</DOCNO>
	<brief_summary>This study aim investigate benefit feasibility provide pharmacogenetic ( PGx ) test part standard medication therapy management ( MTM ) session patient take multiple medication , high-risk population adverse drug reaction non-response . Research participant attend two MTM session undergo PGx test inform MTM plan . Participants also complete 2 survey pre post-MTM/PGx testing . Data analysis ass impact MTM/PGx test recommendation drug dosing , clinical outcome , patient satisfaction , feasibility service delivery . Safety issue minimal primary risk associate loss confidentiality , typical discomfort associate acquire blood sample , genetic discrimination .</brief_summary>
	<brief_title>Medication Therapy Management With Pharmacogenetic Testing</brief_title>
	<detailed_description />
	<criteria>currently prescribe 3 medication , one must simvastatin clopidogrel 18 year age old English speaking patient Mahesh Patel William Kraus Duke Southpoint Clinic patient ever MTM PGx</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>